Stay updated on Nemolizumab Efficacy in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Nemolizumab Efficacy in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nemolizumab Efficacy in Atopic Dermatitis Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The clinical trial record for the nemolizumab study is displayed, including its study design, participant criteria, outcome measures, results-related details, locations, publications, and study documents.
    Difference
    100%
    Check dated 2026-11-11T00:58:28.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0. The study record still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T23:21:39.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    An NIH-wide notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the 403 error page, and the site revision number is updated.
    Difference
    1%
    Check dated 2026-10-20T22:53:21.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T00:28:29.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study content, replacing the original record view with a standard error page. The site chrome (navigation and footer) remains visible, indicating an access restriction rather than a content update.
    Difference
    0.5%
    Check dated 2026-09-30T00:09:01.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study record content. This blocks access to the trial's details and presents a Home option for navigation.
    Difference
    17%
    Check dated 2026-09-23T01:02:41.000Z thumbnail image

Stay in the know with updates to Nemolizumab Efficacy in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nemolizumab Efficacy in Atopic Dermatitis Clinical Trial page.